(Removes reference to Ricks' comment on apology from Lilly in paragraph 3) (Reuters) -Eli Lilly & Co Chief Executive Officer Dave Ricks said on Wednesday that the recent imposter Twitter account incident "demonstrates some of the challenges" on the social…
(Corrects paragraph 2 in Nov. 15 story to show Amazon Pharmacy sells only prescription drugs, not over-the-counter drugs) (Reuters) -Amazon.com Inc on Tuesday launched Amazon clinic, a virtual platform where users can connect with healthcare providers to help treat common…
By Liliana Salgado SCOTTSDALE, Ariz. (Reuters) - Time and death are "on pause" for some people in Scottsdale, Arizona. Inside tanks filled with liquid nitrogen are the bodies and heads of 199 humans who opted to be cryopreserved in hopes…
By Jeff Mason and Doina Chiacu WASHINGTON (Reuters) -President Joe Biden took steps to overhaul U.S. policy on marijuana on Thursday by pardoning thousands of people with federal offenses for simple marijuana possession and initiating a review of how the…
By David Shepardson (Reuters) - General Motors Co on Tuesday said it will not mandate workers return to offices before 2023 after it had told them on Friday that they would be expected to work three days on-campus each week…
By Jeff Mason and Steve Holland WASHINGTON (Reuters) -President Joe Biden celebrated his climate change and drug pricing law, The Inflation Reduction Act, on Tuesday on the White House lawn, highlighting Democrats' commitment to progressive priorities even as high consumer…
WASHINGTON (Reuters) - The roughly $430 billion climate, drugs and tax bill that U.S. Senate Democrats are trying to push through Congress will include a new excise tax on stock buybacks, Majority Leader Chuck Schumer said on Friday. Lawmakers agreed…
(This June 28 story corrects paragraph 5 to say that no injuries were reported after FDA clarifies) (Reuters) - U.S. health regulators on Tuesday classified the recall of some backup batteries of GE Healthcare's ventilators, which the company had initiated…
By Leroy Leo and Mrinalika Roy (Reuters) - Biotech investors nursing losses from stock price falls are now focusing on firms which are closer to getting their drugs to market, rather than those at the early stages of development. This…
By Kanishka Singh WASHINGTON (Reuters) -U.S. Senate Majority Leader Chuck Schumer on Wednesday said he will put bipartisan legislation on lowering insulin costs to a vote on the Senate floor "very soon." "The cost of insulin has skyrocketed in recent…